Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus. (Q51759708)
Jump to navigation
Jump to search
scientific article published on 29 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus. |
scientific article published on 29 March 2012 |
Statements
1 reference
Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus. (English)
1 reference
Masakazu Imamura
1 reference
Keita Nakanishi
1 reference
Takayuki Suzuki
1 reference
Kazuhiro Ikegai
1 reference
Ryota Shiraki
1 reference
Takashi Ogiyama
1 reference
Takeshi Murakami
1 reference
Eiji Kurosaki
1 reference
Atsushi Noda
1 reference
Yoshinori Kobayashi
1 reference
Masayuki Yokota
1 reference
Tomokazu Koide
1 reference
Kazuhiro Kosakai
1 reference
Yasufumi Ohkura
1 reference
Makoto Takeuchi
1 reference
Hiroshi Tomiyama
1 reference
Mitsuaki Ohta
1 reference
29 March 2012
1 reference
20
1 reference
10
1 reference
3263-3279
1 reference
Identifiers
1 reference